Bakhu Holdings, Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended April 30, 2023
June 16, 2023 at 05:04 pm EDT
Share
Bakhu Holdings, Corp. reported earnings results for the third quarter and nine months ended April 30, 2023. For the third quarter, the company reported net loss was USD 3.5 million compared to USD 4.35 million a year ago. Basic loss per share from continuing operations was USD 0.01 compared to USD 0.01 a year ago.
For the nine months, net loss was USD 13.14 million compared to USD 15.56 million a year ago. Basic loss per share from continuing operations was USD 0.04 compared to USD 0.05 a year ago.
Bakhu Holdings, Corp. is a development-stage company. The Company hold a license from Cell Science to plant cell-extraction and replication technology and related equipment, processes, and formulations (the Licensed Science), to produce, manufacture, and sell cannabis-related byproducts - sometimes referred to as cannabinoids in North America, Central America, and the Caribbean for medical, food additive, and recreational uses. The Company is focused on testing and commercializing cannabis plant cell-extraction and replication technologies under a technology license granted by Cell Science. It also intends to sublicense the Licensed Science to third party sub-licensees. The Company has not generated any revenue.